| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.56B | +16.3% |
| Cost of Revenue | $5.35B | +15.1% |
| Gross Profit | $3.21B | +18.2% |
| R&D Expense | $230.0M | -0.9% |
| SG&A Expense | $1.91B | +8.8% |
| Operating Income | $1.01B | +54.8% |
| Pre-tax Income | $1.09B | +71.2% |
| Income Tax | $197.0M | +657.7% |
| Net Income | $890.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.12B | +10.0% |
| Accounts Receivable | $1.67B | +3.2% |
| Inventory | $996.0M | -2.2% |
| Current Assets | $4.10B | +5.5% |
| Total Assets | $16.49B | +2.4% |
| Current Liabilities | $2.34B | +5.9% |
| Long-term Debt | $2.03B | -10.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.26B | +50.9% |
| Investing Cash Flow | -$482.0M | +23.2% |
| Financing Cash Flow | -$615.0M | -291.7% |
| +46.1% |
| EPS (Basic) | $3.67 | +30.6% |
| EPS (Diluted) | $3.65 | +30.8% |
| Total Liabilities |
| $5.61B |
| -5.5% |
| Stockholders' Equity | $10.64B | +4.7% |